Pluto Biosciences, Inc

GSE65267: Next Generation Sequencing identifies Cdh11 and Mrc1 as novel translational biomarkers of kidney fibrosis

Bulk RNA sequencing

Chronic kidney disease (CKD) is the gradual, asymptomatic loss of kidney function. Using a folic acid supplementation model of kidney fibrosis, we report the identification of CDH11 and MRC1 as novel non-invasive biomarkers of CKD. SOURCE: Vishal,S,Vaidya Harvard Medical School

View this experiment on Pluto Biosciences, Inc